Sex Differences in Dose Escalation and Overdose Death during Chronic Opioid Therapy: A Population-Based Cohort Study.
The use of opioids for noncancer pain is widespread, and more than 16,000 die of opioid-related causes in the United States annually. The patients at greatest risk of death are those receiving high doses of opioids. Whether sex influences the risk of dose escalation or opioid-related mortality is un...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4546305?pdf=render |
| _version_ | 1798044592112664576 |
|---|---|
| author | Eric Kaplovitch Tara Gomes Ximena Camacho Irfan A Dhalla Muhammad M Mamdani David N Juurlink |
| author_facet | Eric Kaplovitch Tara Gomes Ximena Camacho Irfan A Dhalla Muhammad M Mamdani David N Juurlink |
| author_sort | Eric Kaplovitch |
| collection | DOAJ |
| description | The use of opioids for noncancer pain is widespread, and more than 16,000 die of opioid-related causes in the United States annually. The patients at greatest risk of death are those receiving high doses of opioids. Whether sex influences the risk of dose escalation or opioid-related mortality is unknown.We conducted a cohort study using healthcare records of 32,499 individuals aged 15 to 64 who commenced chronic opioid therapy for noncancer pain between April 1, 1997 and December 31, 2010 in Ontario, Canada. Patients were followed from their first opioid prescription until discontinuation of therapy, death from any cause or the end of the study period. Among patients receiving chronic opioid therapy, 589 (1.8%) escalated to high dose therapy and n = 59 (0.2%) died of opioid-related causes while on treatment. After multivariable adjustment, men were more likely than women to escalate to high-dose opioid therapy (adjusted hazard ratio 1.44; 95% confidence interval 1.21 to 1.70) and twice as likely to die of opioid-related causes (adjusted hazard ratio 2.04; 95% confidence interval 1.18 to 3.53). These associations were maintained in a secondary analysis of 285,520 individuals receiving any opioid regardless of the duration of therapy.Men are at higher risk than women for escalation to high-dose opioid therapy and death from opioid-related causes. Both outcomes were more common than anticipated. |
| first_indexed | 2024-04-11T23:06:33Z |
| format | Article |
| id | doaj.art-b45eac17c70e4f16a42076ce649b0895 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-11T23:06:33Z |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-b45eac17c70e4f16a42076ce649b08952022-12-22T03:57:59ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01108e013455010.1371/journal.pone.0134550Sex Differences in Dose Escalation and Overdose Death during Chronic Opioid Therapy: A Population-Based Cohort Study.Eric KaplovitchTara GomesXimena CamachoIrfan A DhallaMuhammad M MamdaniDavid N JuurlinkThe use of opioids for noncancer pain is widespread, and more than 16,000 die of opioid-related causes in the United States annually. The patients at greatest risk of death are those receiving high doses of opioids. Whether sex influences the risk of dose escalation or opioid-related mortality is unknown.We conducted a cohort study using healthcare records of 32,499 individuals aged 15 to 64 who commenced chronic opioid therapy for noncancer pain between April 1, 1997 and December 31, 2010 in Ontario, Canada. Patients were followed from their first opioid prescription until discontinuation of therapy, death from any cause or the end of the study period. Among patients receiving chronic opioid therapy, 589 (1.8%) escalated to high dose therapy and n = 59 (0.2%) died of opioid-related causes while on treatment. After multivariable adjustment, men were more likely than women to escalate to high-dose opioid therapy (adjusted hazard ratio 1.44; 95% confidence interval 1.21 to 1.70) and twice as likely to die of opioid-related causes (adjusted hazard ratio 2.04; 95% confidence interval 1.18 to 3.53). These associations were maintained in a secondary analysis of 285,520 individuals receiving any opioid regardless of the duration of therapy.Men are at higher risk than women for escalation to high-dose opioid therapy and death from opioid-related causes. Both outcomes were more common than anticipated.http://europepmc.org/articles/PMC4546305?pdf=render |
| spellingShingle | Eric Kaplovitch Tara Gomes Ximena Camacho Irfan A Dhalla Muhammad M Mamdani David N Juurlink Sex Differences in Dose Escalation and Overdose Death during Chronic Opioid Therapy: A Population-Based Cohort Study. PLoS ONE |
| title | Sex Differences in Dose Escalation and Overdose Death during Chronic Opioid Therapy: A Population-Based Cohort Study. |
| title_full | Sex Differences in Dose Escalation and Overdose Death during Chronic Opioid Therapy: A Population-Based Cohort Study. |
| title_fullStr | Sex Differences in Dose Escalation and Overdose Death during Chronic Opioid Therapy: A Population-Based Cohort Study. |
| title_full_unstemmed | Sex Differences in Dose Escalation and Overdose Death during Chronic Opioid Therapy: A Population-Based Cohort Study. |
| title_short | Sex Differences in Dose Escalation and Overdose Death during Chronic Opioid Therapy: A Population-Based Cohort Study. |
| title_sort | sex differences in dose escalation and overdose death during chronic opioid therapy a population based cohort study |
| url | http://europepmc.org/articles/PMC4546305?pdf=render |
| work_keys_str_mv | AT erickaplovitch sexdifferencesindoseescalationandoverdosedeathduringchronicopioidtherapyapopulationbasedcohortstudy AT taragomes sexdifferencesindoseescalationandoverdosedeathduringchronicopioidtherapyapopulationbasedcohortstudy AT ximenacamacho sexdifferencesindoseescalationandoverdosedeathduringchronicopioidtherapyapopulationbasedcohortstudy AT irfanadhalla sexdifferencesindoseescalationandoverdosedeathduringchronicopioidtherapyapopulationbasedcohortstudy AT muhammadmmamdani sexdifferencesindoseescalationandoverdosedeathduringchronicopioidtherapyapopulationbasedcohortstudy AT davidnjuurlink sexdifferencesindoseescalationandoverdosedeathduringchronicopioidtherapyapopulationbasedcohortstudy |